Estrella Immunopharma, Inc. (ESLA)

NASDAQ: ESLA · Real-Time Price · USD

1.840

-0.010 (-0.54%)

At close: Apr 10, 2026, 4:00 PM EDT

1.770

-0.070 (-3.80%)

After-hours: Apr 10, 2026, 7:35 PM EDT

Estrella Immunopharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022
Selling, General & Admin	2.81	3.2	2.33	0.66	-
Research & Development	10.25	4.11	0.56	10.45	-
Other Operating Expenses	-	-	-	-	1.57
Total Operating Expenses	13.06	7.31	2.89	11.11	1.57
Operating Income	-13.06	-7.31	-2.89	-11.11	-1.57
Interest Income	-	-	-	-	0.65
Total Non-Operating Income (Expense)	-	-	-	-	0.65
Pretax Income	-13.06	-7.31	-2.89	-11.11	-0.92
Provision for Income Taxes	0	0	0.02	-	0.08
Net Income	-13.06	-7.31	-2.89	-11.11	-1
Net Income to Common	-13.06	-7.31	-2.89	-11.11	-1
Shares Outstanding (Basic)	37	27	10	1	1
Shares Outstanding (Diluted)	37	27	10	1	1
Shares Change (YoY)	36.35%	182.63%	575.48%	-	-
EPS (Basic)	-0.35	-0.27	-1.81	-36.35	-0.22
EPS (Diluted)	-0.35	-0.27	-1.81	-36.35	-0.22
Shares Outstanding	37.77	36.29	35.2	3.75	1.42
Free Cash Flow	-1.79	-16.07	-11.54	-1.34	-1.04
Free Cash Flow Per Share	-0.05	-0.59	-1.20	-0.94	-0.74
EBITDA	-13.06	-7.31	-2.89	-11.11	-1.57
EBIT	-13.06	-7.31	-2.89	-11.11	-1.57
Effective Tax Rate	-0.01%	-0.02%	-0.73%	0.00%	-8.81%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q